Abstract
P500 Efficacy and safety of granulocyte, monocyte/macrophage adsorptive apheresis in steroid-dependent active UC with insufficient response or intolerance to immunosuppressants and/or biological therapies (the ART trial): Results at 12 weeks
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have